Related Experiment Video
Updated: Jul 21, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Brain microbiota disruption within inflammatory demyelinating lesions in multiple sclerosis.
W G Branton1,2, J Q Lu2,3, M G Surette4
1Department of Medicine, University of Alberta, Edmonton AB Canada.
Multiple sclerosis (MS) brains show an altered gut microbiome composition, specifically an increase in Proteobacteria. This dysbiosis correlates with inflammatory demyelination, suggesting a role in MS pathogenesis.
Area of Science:
- Neuroscience
- Microbiology
- Immunology
Background:
- Microbial communities are present in healthy tissues but can be disrupted during disease.
- Bacterial components have been detected in brains across various species, even without neurological conditions.
Purpose of the Study:
- To investigate the composition and abundance of microbiota in the brains of multiple sclerosis (MS) patients compared to non-MS controls.
- To explore the relationship between brain microbiota, demyelination, and neuroinflammation in MS.
Main Methods:
- Analysis of frozen and fixed autopsied brain samples using neuropathological, molecular, and bioinformatics tools.
- 16S rRNA sequencing and RNA sequencing (RNAseq) to identify bacterial composition and gene expression.
- Immunohistochemistry to detect bacterial components like peptidoglycan (PGN).
Main Results:
- Proteobacteria were the dominant phylum with reduced diversity in the cerebral white matter (WM) of MS patients compared to controls.
- Both groups had similar bacterial genome counts (1,200-1,400/cm³), but MS brains showed a predominance of Proteobacteria linked to increased inflammatory gene expression.
- PGN immunodetection correlated significantly with demyelination and neuroinflammation in MS brains, with these factors explaining 86% of the variance.
Conclusions:
- Multiple sclerosis is associated with an organ-specific dysbiosis, characterized by an altered brain microbial composition.
- The findings suggest a link between inflammatory demyelination and microbial dysbiosis in the pathogenesis of MS.
- Bacterial components, particularly PGN, may play a role in driving neuroinflammation and demyelination in MS.
More Related Videos
Related Concept Videos
Introduction to the Human Microbiota
Dysbiosis of the Gut Microbiota
Gut-Brain Axis
Microbiota Modulation by Antibiotics
Bacterial Meningitis II: Pathophysiology
Multiple Sclerosis l: Introduction

